ATLAS / Macro Radar / Reporting / CTXR

Citius Pharmaceuticals, Inc. (CTXR) reporting calendar

Citius Pharmaceuticals, Inc. files periodic reports with the SEC as CTXR on Nasdaq. Atlas tracks 59 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
59

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CTXR market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001213900-26-057842
10-Q31 Dec 202513 Feb 202644 days0001213900-26-015878
10-K30 Sep 202523 Dec 202584 days0001213900-25-125333
10-Q30 Jun 202512 Aug 202543 days0001213900-25-074997
10-Q31 Mar 202514 May 202544 days0001213900-25-043360
10-Q31 Dec 202414 Feb 202545 days0001213900-25-014321
10-K30 Sep 202427 Dec 202488 days0001213900-24-113149
10-Q30 Jun 202412 Aug 202443 days0001213900-24-067732
10-Q31 Mar 202414 May 202444 days0001213900-24-042920
10-Q31 Dec 202314 Feb 202445 days0001213900-24-014096
10-K30 Sep 202329 Dec 202390 days0001213900-23-099889
10-Q30 Jun 202314 Aug 202345 days0001213900-23-067024
10-Q31 Mar 202312 May 202342 days0001213900-23-039031
10-Q31 Dec 202210 Feb 202341 days0001213900-23-010315
10-K30 Sep 202222 Dec 202283 days0001213900-22-082217
10-Q30 Jun 202211 Aug 202242 days0001213900-22-046897
10-Q31 Mar 202212 May 202242 days0001213900-22-025975
10-Q31 Dec 202110 Feb 202241 days0001213900-22-006429
10-K30 Sep 202115 Dec 202176 days0001213900-21-065464
10-Q30 Jun 202112 Aug 202143 days0001213900-21-042071
10-Q31 Mar 202113 May 202143 days0001213900-21-025920
10-Q31 Dec 202011 Feb 202142 days0001213900-21-008453
10-K30 Sep 202016 Dec 202077 days0001213900-20-043004
10-Q30 Jun 202014 Aug 202045 days0001213900-20-022331
10-Q31 Mar 202014 May 202044 days0001213900-20-012286
10-Q31 Dec 201913 Feb 202044 days0001213900-20-003577
10-K30 Sep 201916 Dec 201977 days0001213900-19-026259
10-Q30 Jun 201914 Aug 201945 days0001213900-19-015793
10-Q31 Mar 201915 May 201945 days0001213900-19-008833
10-Q31 Dec 201814 Feb 201945 days0001213900-19-002563
10-K30 Sep 201811 Dec 201872 days0001213900-18-017214
10-Q30 Jun 201814 Aug 201845 days0001213900-18-011072
10-Q31 Mar 201811 May 201841 days0001213900-18-005952
10-Q31 Dec 201714 Feb 201845 days0001213900-18-001880
10-K30 Sep 201713 Dec 201774 days0001213900-17-013191
10-Q30 Jun 201714 Aug 201745 days0001477932-17-003946
10-Q31 Mar 201715 May 201745 days0001477932-17-002308
10-Q31 Dec 201614 Feb 201745 days0001477932-17-000773
10-K30 Sep 201623 Dec 201684 days0001477932-16-014315
10-Q30 Jun 201615 Aug 201646 days0001477932-16-011894

Source: SEC EDGAR company submissions for CIK 0001506251. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.